Abstract | OBJECTIVES: STUDY DESIGN: A total of 54 children including 27 with VVS, aged 6-16 years (mean age 11.3 ± 3.3 years), and 27 healthy children, aged 3-17 years (mean age 10.4 ± 1.8 years) were included in the study. Children with VVS had symptoms of dizziness, pallor, blurred vision, nausea, and some had syncope. Erythrocyte H2S production was measured by a sulphur-sensitive electrode. Flow-mediated dilation (FMD) of brachial artery was measured for each patient by vascular ultrasound. RESULTS: H2S production from erythrocytes was significantly increased in the children with VVS compared with controls (P < .01). The erythrocytic H2S production in the VVS-vasoinhibitory subgroup was obviously higher than that in VVS-cardioinhibitory (P < .05) and VVS-mixed inhibitory subgroups (P < .05). FMD in the VVS-vasoinhibitory subgroup was greater than that in the VVS-cardioinhibitory (P < .05) and the VVS-mixed subgroups (P < .05). The erythrocytic H2S production had a positive linear correlation with FMD in children with VVS (P < .05). CONCLUSIONS: Increased erythrocyte H2S production may be involved in the pathogenesis of VVS in children.
|
Authors | Jinyan Yang, Hongxia Li, Todd Ochs, Juan Zhao, Qingyou Zhang, Shuxu Du, Yonghong Chen, Ping Liu, Yuli Wang, Xueli Feng, Chunyu Zhang, Chaoshu Tang, Junbao Du, Hongfang Jin |
Journal | The Journal of pediatrics
(J Pediatr)
Vol. 166
Issue 4
Pg. 965-9
(Apr 2015)
ISSN: 1097-6833 [Electronic] United States |
PMID | 25641243
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2015 Elsevier Inc. All rights reserved. |
Chemical References |
- Biomarkers
- Hydrogen Sulfide
|
Topics |
- Adolescent
- Biomarkers
(blood)
- Child
- Child, Preschool
- Disease Progression
- Electrocardiography
- Erythrocytes
(metabolism)
- Female
- Follow-Up Studies
- Heart Rate
(physiology)
- Humans
- Hydrogen Sulfide
(blood)
- Male
- ROC Curve
- Syncope, Vasovagal
(blood, diagnosis, physiopathology)
- Tilt-Table Test
|